U.S. Markets open in 5 hrs 25 mins

Esperion Therapeutics reports 4Q loss

ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Wednesday reported a loss of $29 million in its fourth quarter.

On a per-share basis, the Ann Arbor, Michigan-based company said it had a loss of $1.29.

For the year, the company reported that its loss widened to $75 million, or $3.33 per share.

Esperion Therapeutics shares have increased 95 percent since the beginning of the year. The stock has risen 53 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR

_____

Keywords: Esperion Therapeutics, Earnings Report